亨迪药业 (301211.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(亨迪药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年三季报2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报
主要指标:
 营业收入(元) 333,993,687.09241,866,955.11138,059,120.72663,025,874.35542,445,746.24405,758,580.58193,286,953.47
 营业利润(元) 82,958,023.6681,129,769.4444,340,764.81205,334,070.12171,168,058.78133,790,701.8848,111,805.96
 利润总额(元) 82,580,556.8380,885,172.5044,323,592.98202,816,100.34170,786,541.22133,645,437.1047,938,084.65
 净利润(元) 74,661,546.2868,496,011.3137,381,597.20176,116,201.67144,514,979.02113,038,868.4139,922,932.84
 归属于母公司股东的净利润(元) 74,661,546.2868,496,011.3137,381,597.20176,116,201.67144,514,979.02113,038,868.4139,922,932.84
盈利能力:
 销售毛利率(%) 30.2336.0037.9240.1740.7539.4032.22
 销售净利率(%) 22.3528.3227.0826.5626.6427.8620.65
 净资产收益率(%) 3.232.991.59----
 总资产报酬率ROA(%) 1.561.601.06----
 投入资本回报率ROIC(%) 3.202.941.577.596.254.931.74
营运能力:
 存货周转率(次) 1.621.020.59----
 应收账款周转率(次) 4.822.921.96----
 总资产周转率(次) 0.140.100.05----
偿债能力:
 资产负债率(%) 5.815.795.807.466.897.946.61
 股东权益比率(%) 94.1994.2194.2092.5493.1192.0693.39
 已获利息倍数(倍) -0.87-0.95-1.50-3.01-3.35-3.74-3.13
 流动比率 14.6214.9715.4711.9813.2611.5414.49
 速动比率 13.3013.4814.1410.9112.3110.7313.45
发展能力:
 营业收入增长率(%) -38.43-40.39-28.5728.7656.9368.8050.72
 营业利润增长率(%) -51.53-39.36-7.8438.0682.86104.5442.15
 税后利润增长率(%) -48.34-39.40-6.3740.0083.98107.8042.76
 净资产增长率(%) -1.35-0.283.373.524.370.762.93
 总资产增长率(%) -2.47-2.562.481.918.034.635.07

前瞻产业研究院